Ebola

Bats act as reservoirs of numerous zoonotic viruses, including SARS-CoV, MERS CoV, Ebola virus and—most likely—SARS-CoV-2, the pathogen behind the ongoing pandemic. However, the molecular mechanisms bats deploy to tolerate pathogenic viruses h...

A reporter who covered an Ebola outbreak in West Africa discovers troubling parallels in the U.S. over the coronavirus, including conspiracy theories and denial....

The drug, given intravenously, is supposed to work by blocking the virus' ability to reproduce and spread in the body. It is believed to cut hospital stay for admitted patients by four to five days....

THE US has approved an antiviral drug, originally developed to treat Ebola, to be used for coronavirus patients in a major step forward....

The drug was first developed to treat Ebola, a viral hemorrhagic fever...

Remdesivir, an antiviral drug originally developed to treat Ebola, has been approved for use on COVID-19 patients in the US....

Last week the first treatment for any kind of Ebola was approved by the FDA. Expert virologist Professor Daniel Bausch comments on its significance....

The biotech sector was in focus as Biogen's (BIIB) Q3 results disappoint, Vertex (VRTX) stops study and Regeneron's (REGN) Ebola drug gets FDA approval....

The study, carried out in a joint effort by British and Guinean scientists, is the world's largest and most comprehensive study to date to examine survivors of the Ebola virus....

Most of us don't know what COVID-19 looks like. We recall from Science class that smallpox came with gross and unsightly spots and lesions and that folks with Ebola bled frighteningly, but this appears to be a "quiet" disease. We're only a...

Regeneron — the pharmaceutical company developing COVID-19 treatments — has just received FDA approval for the first drug aimed at another infectious disease that's been in the headlines....

While scientists work to develop effective treatments for COVID-19, there is good news on another disease front. This month the U.S. Food and Drug Administration granted formal approval to an antibody cocktail from the pharmaceutical company Regeneron tha...

As the world grapples with COVID-19, the Ebola virus is again raging. Researchers are using supercomputers to simulate the inner workings of Ebola (as well as COVID-19), looking at how molecules move, atom by atom, to carry out their functions. Now, they ...

Fishmongers say business has nose-dived after Ebola returned to DRC....

The Ebola virus causes a serious infection with a mortality rate between 50% and 90%. Nucleoproteins in the virus assemble into a helical arrangement and encapsulate a single stranded RNA genome, ssRNA, to form a rodlike complex known as a nucleocapsid, w...

Scientists at the University of Delaware report a computational study of the Ebola virus nucleocapsid and show that the binding of the ssRNA allows the nucleocapsid to maintain its shape and structural integrity....

As the world grapples with COVID-19, the Ebola virus is again raging. A research team at University of Delaware is using supercomputers to simulate the inner workings of Ebola (as well as COVID-19), looking at how molecules move, atom by atom, to carry ou...

The World Health Organization (WHO) said on Thursday it was setting up a seven-person independent commission to investigate claims of sexual exploitation and abuse by aid workers during the recent Ebola outbreak in Democratic Republic of Congo....

Research finds Ebola survivors showing no antibodies still have lasting capacity to fight virus...

WE must recognise that more zoonotic diseases, such as SARS, Dengue, Ebola and Covid-19, may arise with increasing frequency and with more fatal outcomes as a consequence of the relentless process of forest clearance bringing humanity into ever closer con...

The diagnosis — delivered at a distance of 6 feet in the doctor's office — was a shock. It brought back memories of my work in the Ebola ward. Then as now, an intimate touch was a rare thing....

Top Stories from around the globe brought to you by dpa International....

The Food and Drug Administration has approved a drug tested during the 2018 Ebola epidemic — a sign of what could come with the coronavirus....

U.S. regulators Wednesday approved the first drug for the treatment of Ebola. The Food and Drug Administration OK'd the drug developed by Regeneron Pharmaceuticals for treating adults and children with the Zaire Ebola virus strain, the most deadly of ...

Lab-made antibodies developed by Regeneron marshal an immune response and curb the Ebola virus's ability to infect cells....

The World Health Organization (WHO) said on Thursday it was setting up a seven-person independent commission to investigate claims of sexual exploitation and abuse by aid workers during the recent Ebola outbreak in Democratic Republic of Congo....

The World Health Organization (WHO) said on Thursday it was setting up a seven-person independent commission to investigate claims of sexual exploitation and abuse by aid workers during the recent Ebola outbreak in Democratic Republic of Congo....

Sex abuse victims' advocate will help lead commission investigating claims of sexual exploitation by aid workers in Congo Ebola outbreak...

The Food and Drug Administration (FDA) announced the first-ever approval of an Ebola drug, which is made of three monoclonal antibodies....

The World Health Organization says it has created a commission to investigate allegations of sexual abuse and exploitation committed by WHO workers during the response to the tenth Ebola virus epidemic in the Democratic Republic of Congo. According to a W...

Approval may bolster hopes for Regeneron's COVID-19 therapy, which uses same strategy....

Regeneron Pharmaceuticals got approval for the antibody mixture after it was tested on 382 children and adults....

Regeneron (REGN) gets FDA nod for its triple antibody cocktail for the treatment of infection caused by Zaire ebolavirus in adult and pediatric patients....

The World Health Organization (WHO) said on Thursday it was setting up a seven-person independent commission to investigate claims of sexual exploitation and abuse by aid workers during the recent Ebola outbreak in Democratic Republic of Congo....

The World Health Organization (WHO) said on Thursday it was setting up a seven-person independent commission to investigate claims of sexual exploitation and abuse by aid workers during the recent Ebola outbreak in Democratic Republic of Congo....

U.S.A. (AP) (10/15/20)— U.S. regulators on Wednesday approved the first drug for the treatment of Ebola. The Food and Drug Administration OK'd the drug developed by Regeneron Pharmaceuticals for treating adults and children with the Zaire Ebola ...

Survival was significantly better in study participants given the drug developed by Regeneron or a second experimental drug....

Regeneron's treatment is a combination of three antibodies that work by killing the virus...

Survival was significantly better in study participants given the drug developed by Regeneron or a second experimental drug....

Survival was significantly better in study participants given the Regeneron drug or a second experimental drug....

U.S. regulators Wednesday approved the first drug for the treatment of Ebola.The Food and Drug Administration OK'd the drug developed by Regeneron Pharmaceuticals for treating adults and children with the Zaire Ebola virus strain, the most deadly of s...

US regulators approve 1st treatment for Ebola...

Survival was significantly better in study participants given the drug developed by Regeneron or a second experimental drug....

Survival was significantly better in study participants given the Regeneron drug or a second experimental drug....

The World Health Organization has appointed two distinguished leaders to co-chair an Independent Commission on sexual abuse and exploitation during the response to the tenth Ebola Virus Disease epidemic in the provinces of North Kivu and Ituri, the Democr...

U.S. regulators Wednesday approved the first drug for the treatment of Ebola. The Food and Drug Administration OK'd the drug developed by Regeneron Pharmaceuticals for treating adults and children with the Zaire Ebola virus strain, the most deadly of ...

The treatment, Inmazeb, underwent trials in the Democratic Republic of the Congo, which recently declared its 11th Ebola outbreak in just over 40 years....